IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 97 filers reported holding IMMUNOVANT INC in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,804,583 | +1372.3% | 359,588 | +627.5% | 0.04% | +1750.0% |
| Q2 2023 | $937,593 | +15.2% | 49,425 | -5.8% | 0.00% | 0.0% |
| Q1 2023 | $814,151 | +7.8% | 52,492 | +23.3% | 0.00% | 0.0% |
| Q4 2022 | $755,582 | +1273.8% | 42,568 | +331.7% | 0.00% | – |
| Q3 2022 | $55,000 | -99.3% | 9,860 | -99.5% | 0.00% | -100.0% |
| Q2 2022 | $7,341,000 | -30.0% | 1,882,351 | -1.1% | 0.02% | -16.7% |
| Q1 2022 | $10,491,000 | +146.5% | 1,903,894 | +281.2% | 0.02% | +200.0% |
| Q4 2021 | $4,256,000 | +3666.4% | 499,490 | +3732.2% | 0.01% | – |
| Q3 2021 | $113,000 | -98.6% | 13,034 | -92.4% | 0.00% | -100.0% |
| Q4 2020 | $7,901,000 | +927.4% | 171,059 | +682.3% | 0.02% | +700.0% |
| Q3 2020 | $769,000 | – | 21,866 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |